These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis? Brewer D J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370 [TBL] [Abstract][Full Text] [Related]
25. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride. Andrassy K Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic use of low molecular weight heparins: the knowledge to date as applied to therapy. Hull RD; Pineo GF Semin Thromb Hemost; 1993; 19 Suppl 1():111-5. PubMed ID: 8395712 [TBL] [Abstract][Full Text] [Related]
31. Low molecular weight heparins: antithrombotic and haemorrhagic effects and standardization. Barrowcliffe TW; Thomas DP Acta Chir Scand Suppl; 1988; 543():57-64. PubMed ID: 2847459 [TBL] [Abstract][Full Text] [Related]
32. Differentiation of low-molecular-weight heparins: impact on the future of the management of thrombosis. Fareed J; Ma Q; Florian M; Maddineni J; Iqbal O; Hoppensteadt DA; Bick RL Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():89-104. PubMed ID: 15085470 [TBL] [Abstract][Full Text] [Related]
33. Past, present and future considerations on low molecular weight heparin differentiation: an epilogue. Fareed J; Haas S; Sasahar A Semin Thromb Hemost; 1999; 25 Suppl 3():145-7. PubMed ID: 10549730 [TBL] [Abstract][Full Text] [Related]
34. Comparative pharmacology of low molecular weight heparins: implications of manufacturing processes on biological effects. Doutremepuich C; Guyot M; Lalanne MC; Deharo E; Walenga JM; Fareed J Thromb Res; 1989 Aug; 55(4):419-26. PubMed ID: 2554524 [TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparin. Wolf H Med Clin North Am; 1994 May; 78(3):733-43. PubMed ID: 8170267 [TBL] [Abstract][Full Text] [Related]
38. Could non steroidal anti-inflammatory drugs be used to potentiate L.M.W.H. activity in thrombosis? (Part II). Doutremepuich F; Lalanne MC; Slimani M; Doutremepuich C Thromb Res; 1992 May; 66(4):445-9. PubMed ID: 1329259 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of an intervention on the prescription and biological surveillance of low-molecular weight heparins in medicine]. Fiessinger JN; Chatellier G Presse Med; 1996 Nov; 25(36):1777-80. PubMed ID: 8991025 [TBL] [Abstract][Full Text] [Related]